BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $693,861 | +28.1% | 98,003 | +27.4% | 0.00% | – |
| Q2 2023 | $541,559 | -12.8% | 76,926 | +3.4% | 0.00% | – |
| Q1 2023 | $620,738 | -27.0% | 74,429 | +0.5% | 0.00% | -100.0% |
| Q4 2022 | $850,473 | -8.1% | 74,083 | +0.9% | 0.00% | 0.0% |
| Q3 2022 | $925,495 | +17.0% | 73,452 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $790,717 | -34.1% | 74,737 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $1,199,582 | -4.6% | 73,775 | -18.7% | 0.00% | 0.0% |
| Q4 2021 | $1,257,000 | -3.5% | 90,725 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $1,302,000 | -17.2% | 90,587 | -8.9% | 0.00% | 0.0% |
| Q2 2021 | $1,573,000 | +56.2% | 99,490 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $1,007,000 | +27.3% | 99,064 | -6.7% | 0.00% | 0.0% |
| Q4 2020 | $791,000 | +130.6% | 106,152 | +6.4% | 0.00% | – |
| Q3 2020 | $343,000 | -25.4% | 99,752 | +7.9% | 0.00% | – |
| Q2 2020 | $460,000 | +134.7% | 92,419 | -5.8% | 0.00% | – |
| Q1 2020 | $196,000 | -19.7% | 98,150 | +38.6% | 0.00% | – |
| Q4 2019 | $244,000 | +6.6% | 70,820 | -2.0% | 0.00% | – |
| Q3 2019 | $229,000 | -16.4% | 72,273 | 0.0% | 0.00% | – |
| Q2 2019 | $274,000 | -53.2% | 72,273 | +0.7% | 0.00% | -100.0% |
| Q1 2019 | $585,000 | +7.1% | 71,800 | +6.1% | 0.00% | 0.0% |
| Q4 2018 | $546,000 | -2.2% | 67,649 | -7.6% | 0.00% | 0.0% |
| Q3 2018 | $558,000 | +27.4% | 73,189 | -4.4% | 0.00% | – |
| Q2 2018 | $438,000 | +21.7% | 76,549 | +1.4% | 0.00% | – |
| Q1 2018 | $360,000 | -4.5% | 75,505 | -1.6% | 0.00% | – |
| Q4 2017 | $377,000 | +14.2% | 76,741 | +21.8% | 0.00% | – |
| Q3 2017 | $330,000 | -6.0% | 62,981 | -0.2% | 0.00% | – |
| Q2 2017 | $351,000 | -29.5% | 63,116 | +6.4% | 0.00% | -100.0% |
| Q1 2017 | $498,000 | +51.4% | 59,342 | +14.0% | 0.00% | – |
| Q4 2016 | $329,000 | +38.2% | 52,067 | -3.5% | 0.00% | – |
| Q3 2016 | $238,000 | +51.6% | 53,983 | -2.3% | 0.00% | – |
| Q2 2016 | $157,000 | +18.0% | 55,229 | +13.4% | 0.00% | – |
| Q1 2016 | $133,000 | -73.2% | 48,722 | +1.3% | 0.00% | – |
| Q4 2015 | $496,000 | -8.7% | 48,096 | +1.0% | 0.00% | -100.0% |
| Q3 2015 | $543,000 | -84.5% | 47,598 | -79.7% | 0.00% | -75.0% |
| Q2 2015 | $3,498,000 | +732.9% | 234,331 | +403.7% | 0.00% | +300.0% |
| Q1 2015 | $420,000 | -23.1% | 46,523 | +3.5% | 0.00% | 0.0% |
| Q4 2014 | $546,000 | +21.6% | 44,942 | -2.2% | 0.00% | 0.0% |
| Q3 2014 | $449,000 | -21.0% | 45,973 | +3.1% | 0.00% | 0.0% |
| Q2 2014 | $568,000 | +3055.6% | 44,602 | +2469.2% | 0.00% | – |
| Q1 2014 | $18,000 | +50.0% | 1,736 | +7.1% | 0.00% | – |
| Q4 2013 | $12,000 | 0.0% | 1,621 | +1.3% | 0.00% | – |
| Q3 2013 | $12,000 | +500.0% | 1,600 | 0.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |